agilon health (NYSE: AGL) insider transactions
In the twelve months to 10 November 2026, executives and directors of agilon health reported 0 open-market sales and 5 open-market purchases of 623,431 shares ($351,030), by 4 people, according to the Form 4 filings they submitted to the SEC.
Latest transactions
| Date | Insider | Role | Transaction | Shares | Price | Held after | Filing |
|---|---|---|---|---|---|---|---|
| 16 August 2026 | Gertsch Timothy | Chief Accounting Officer | Shares withheld for tax | −17 | $96.90 | 14,152 | Form 4 |
| 1 August 2026 | Zamore Denise | Chief Legal Officer | Shares withheld for tax | −37 | $91.61 | 66,075 | Form 4 |
| 1 July 2026 | Schwaneke Jeffrey A. | Chief Financial Officer | Shares withheld for tax | −2,311 | $111.74 | 138,031 | Form 4 |
| 2 June 2026 | Battaglia Silvana | Director | Grant or award | +2,133 | — | 7,926 | Form 4 |
| 2 June 2026 | Mansukani Sharad | Director | Grant or award | +2,133 | — | 56,242 | Form 4 |
| 2 June 2026 | McKenzie Diana | Director | Grant or award | +2,133 | — | 7,633 | Form 4 |
| 2 June 2026 | McLoughlin Karen | Director | Grant or award | +2,133 | — | 8,207 | Form 4 |
| 2 June 2026 | Williams Ronald A | Director | Grant or award | +2,133 | — | 149,141 | Form 4 |
| 2 June 2026 | Wulf John William | Director | Grant or award | +2,133 | — | 16,765 | Form 4 |
| 1 June 2026 | Zamore Denise | Chief Legal Officer | Shares withheld for tax | −485 | $92.54 | 66,112 | Form 4 |
| 24 May 2026 | Gertsch Timothy | Chief Accounting Officer | Shares withheld for tax | −8 | $86.39 | 14,169 | Form 4 |
| 7 May 2026 | O'Rourke Timothy Patrick | CEO & President | Grant or award | +120,000 | — | 120,000 | Form 4 |
| 7 May 2026 | O'Rourke Timothy Patrick | CEO & President | Grant or award | +200,000 | — | 320,000 | Form 4 |
| 15 April 2026 | Shaker Benjamin | Chief Markets Officer | Shares withheld for tax | −571 | $26.88 | 122,850 | Form 4 |
| 15 April 2026 | Gertsch Timothy | Chief Accounting Officer | Shares withheld for tax | −122 | $26.88 | 14,177 | Form 4 |
| 15 April 2026 | Venkatachaliah Girish | Chief Technology Officer | Shares withheld for tax | −330 | $26.88 | 38,236 | Form 4 |
| 15 April 2026 | Zamore Denise | Chief Legal Officer | Shares withheld for tax | −220 | $26.88 | 66,597 | Form 4 |
| 14 April 2026 | Shaker Benjamin | Chief Markets Officer | Shares withheld for tax | −104 | $22.68 | 123,421 | Form 4 |
| 14 April 2026 | Gertsch Timothy | Chief Accounting Officer | Shares withheld for tax | −25 | $22.68 | 14,299 | Form 4 |
| 14 April 2026 | Venkatachaliah Girish | Chief Technology Officer | Shares withheld for tax | −96 | $22.68 | 38,566 | Form 4 |
Names appear as in the filing, surname first. A dash in the price column means the filing reports none, as in grants and gifts.
How to read the table
Only open-market purchases and sales are trades the insider chose to make at the market price, and they are the ones counted in the summary above. Grants, option exercises and shares withheld for tax come from pay plans. A sale marked as a 10b5-1 plan was scheduled in advance under a written plan.
Where each row comes from
From the Form 4 that each executive, director or large shareholder must file with the SEC within two business days of a transaction, read up to 10 November 2026. Each row links to its filing on EDGAR. Only transactions in shares are listed, not derivatives, and amended filings are left out. The accounts of the company are on the agilon health page; the method, in data sources.
Information prepared from the Form 4 filings submitted to the SEC, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.